This is a free preview of June 29th’s Newsletter. Consider signing up for a subscription over on the right sidebar if this is your jam. (Or just subscribe to The Athletic San Diego, where my writing can also be found).
Part two of the two-part Twitter mailbag incoming in five . . . four . . . three . . . ahh, what the heck, here it is:
@jefftsd: How about a compare and contrast of Urias’ 2018 YTD numbers vs. his 2017 numbers? Is his 2018 so far a step backwards, normal growing pains, or do you think his numbers are OK? Just an idea, I don’t remember you recently covering the topic.
Good topic. Just to get the particulars out of the way, Luis Urias is 21 years old and currently playing (mostly) second base at Triple-A El Paso. Through 321 plate appearances, he’s slashing .268/.377/.408 with a 112 wRC+.
The place to start with Urias is the strikeouts, I think. After walking more than he whiffed in every season going into this one, Triple-A pitching has caught up to Urias. He has 64 strikeouts to 43 walks after striking out just 65 times all of last season. The walks aren’t a problem—Urias is actually walking at a career-high 13.4 percent clip, an impressive number given the age and level.
The early concern is that strikeout rate, which has ballooned this season. Going into this year, Urias had an 8.8 percent K rate in his professional career, the stuff of a bat-to-ball legend. This year? It’s at 19.9 percent. As mentioned, Urias is just 21 and at Triple-A, so an increase in whiffs was expected. But even last year, as a 20-year-old at Double-A (and in a tougher hitter’s environment), Urias only K’ed in 12.4 percent of his PAs. It’s not like he needed a bunch of time to adjust to Double-A last season, either; through the first three months of 2017, his K rate was lower than his seasonal mark, at 11.5 percent.
Continue reading “Checking in on Luis Urias”
During yesterday’s game, Andy Green made a curious move. Trailing 5–1 in the third inning, Green pulled a double-switch, removing Manuel Margot from center and putting Matt Szczur in his place. The move perhaps made a touch of strategic sense—it moved the pitcher’s spot from ninth to eighth in the lineup, so new hurler Robbie Erlin didn’t have to bat until the bottom of the fifth. Still, it was super early for a double-switch; avoiding a low-leverage at-bat from the pitcher’s spot in the third inning is hardly a needle-mover. If you believe Margot is a better player than Szczur, you can’t remove him in the third for a double-switch. (And if you don’t, perhaps Szczur should have just started the game.)
Without an easy-to-explain injury—one apparently wasn’t mentioned after the game—the move just didn’t make a whole lot of sense, but it perhaps highlighted a difference in priorities between Green and the Padres front office.
The question about who’s better between Margot and Szczur right now is possibly an open one, but we can probably all agree on one thing: Margot has a future in the organization and Szczur does not—at least not unless he’s willing to drop his spare outfielder gig for one as a roving instructor. And even if the switch might have made some sense from a win expectancy standpoint—not a given, by the way—it just didn’t jibe in the big scheme of things. The Padres were facing a left hander and a bad team, and Margot, so long as he’s on the team, should get as many at-bats as is reasonable. Starting him and then removing him after one plate appearance isn’t doing anybody any good.
Of course, if Green is doing everything he can to squeeze an extra point of win expectancy out of a thin roster, maybe it’s hard to blame him.
Continue reading “The Conflicting Priorities of Andy Green”
Yesterday, on an entertaining edition of the Gwynntelligence podcast, the guys—HJ Preller and, this time, Woe Doctor—brought up David Marver’s recent tweets on Fernando Tatis Jr., which dovetailed into a good discussion on the riskiness of prospects and the inherent danger in relying too much on one player.
If you follow me on Twitter or have read any of my prospect-related love letters stuff over the last couple of years, you probably have a pretty good idea about my thoughts on Tatis. I once, for instance, ranked him as the Padres top 11 prospects. Yes, all of them. Of course, it’s important to consider the risks broached on Gwynntelligence and by Marver; I certainly understand that Tatis could bust completely or, more likely, simply become a so-so major-league player instead of a superstar, and I don’t want to be charged with overhyping him. The very early performance in Double-A—a .235/.250/.318 slash line with a 28.4 percent strikeout rate in 21 games—is perhaps a flickering warning sign that his developmental path could hit some rocky roads, especially with the way the Padres have fast-tracked him.
Then again, I remain almost unflinchingly high on Tatis, despite the risks and spotty recent performance. It’s certainly plausible that we, as observers of the Padres, are sometimes not great at respecting the risks. But I also think it’s possible that we’re just not used to dealing with a prospect of Tatis’ caliber, one who’s currently rated as a top 10 prospect by three of the biggest prospect-ranking outlets out there (Baseball America, Baseball Prospectus, and MLB.com) and just as high (or higher) elsewhere, like ESPN’s Keith Law or FanGraphs.
The Padres haven’t had a prospect this good in . . .well, a long time. First basemen like Anthony Rizzo and Yonder Alonso never even cracked the top 30 on an individual prospect list; Yasmani Grandal hovered around 50; Manuel Margot got close to the top 10 but never into it; even Jake Peavy only reached a peak of 28 back in 2002. The last Padres prospect this highly regarded was probably Sean Burroughs, who hit No. 4 on Baseball America’s list in 2002.
Continue reading “Fernando Tatis Jr. is in Good Company”
What’s the deal with Dinelson?
As we discussed on Monday, Dinelson Lamet left his Sunday start with soreness in his right elbow. The Padres have since diagnosed Lamet with a flexor strain—a muscle issue—and ruled him out for April. At first blush, it’s great news. Anytime an elbow issue finds a pitcher, Tommy John surgery immediately jumps to mind. Flexor strain, then, is a pitcher’s best friend.
Still, like much of Padres Twitter, I can’t quite understand why the Padres haven’t given Lamet an MRI yet. Team doctors apparently diagnosed Lamet through some type of surface examination. That’s cool, I guess—I’m no fan of modern medicine myself, but I’m also not a major-league pitcher or someone who has to make decisions regarding the future of one. It seems like it’d be in the best interest of the Padres, Lamet, and everyone involved to order the MRI, just to double-check whether there could be structural damage in his ligament.
The lack of an MRI so far seems silly, but I like to believe that teams generally act rationally, particularly when confronted with something like this, something that could potentially hurt their on-field product—and, thus, their revenue stream. So . . . what’s the deal?
Continue reading “MRIs and Service Time”